Cleveland Clinic Says It Won’t Give Patients Aduhelm

In a striking reflection of the concern over approval of the controversial new Alzheimer’s drug Aduhelm, the Cleveland Clinic said Wednesday evening that it will not be administering it to patients. The clinic, one of the nation’s largest and most respected medical centers, said in a statement that a panel of experts “reviewed all available …